Phase II Trial of M7824 in Subjects With HPV Associated Malignancies

Trial Profile

Phase II Trial of M7824 in Subjects With HPV Associated Malignancies

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Feb 2018

At a glance

  • Drugs MSB 0011359C (Primary)
  • Indications Anal cancer; Cervical cancer; Human papillomavirus infections; Neuroendocrine carcinoma; Oropharyngeal cancer; Penile cancer; Rectal cancer; Squamous cell cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Feb 2018 Planned initiation date changed from 15 Feb 2018 to 19 Feb 2018.
    • 12 Feb 2018 New trial record
    • 09 Feb 2018 Planned initiation date changed from 14 Feb 2018 to 15 Feb 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top